View in EDS HTML Full Text PDF Full Text

Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.

Saved in:
Bibliographic Details
Title: Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Authors: Shadman, Mazyar1 (AUTHOR) mshadman@fredhutch.org, Salkar, Monika2 (AUTHOR), Srivastava, Bhavini2 (AUTHOR), Karve, Sudeep2 (AUTHOR), Emond, Bruno3 (AUTHOR), Gogna, Priyanka3 (AUTHOR), Manceur, Ameur M.3 (AUTHOR), Lafeuille, Marie-Hélène3 (AUTHOR), Rava, Andrew4 (AUTHOR), Sun, Haiyan4 (AUTHOR), Howarth, Amanda4 (AUTHOR), Tomicki, Samantha4 (AUTHOR), Agatep, Barnabie5 (AUTHOR), Jones, Barton5 (AUTHOR), Franceschini, Erin2 (AUTHOR), Saifan, Chadi2 (AUTHOR), Bacchus, Shaffee2 (AUTHOR), Roeker, Lindsey6 (AUTHOR), Stephens, Deborah M.7 (AUTHOR)
Source: Leukemia & Lymphoma. Jan2025, Vol. 66 Issue 1, p44-53. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2024.2402814